Literature DB >> 17237555

Cord-blood mesenchymal stem cells and tissue engineering.

Curtis L Cetrulo1.   

Abstract

Institute of Reconstructive Plastic Surgery, Laboratory of Vascular Tissue Engineering and Microvascular Research, New York University, New York, NY and Long Island Plastic Surgical Group, Garden City, NY Cord-blood-derived stem cells have proven clinically useful for numerous disease states, as have mesenchymal stem cells (MSCs) derived from bone marrow and adipose tissue. The recent identification of MSCs in cord-blood heralds cord-blood as an untapped resource for nonhematopoietic stem cell-based therapeutic strategies for the replacement of injured or diseased connective tissue. This review discusses the potential for tissue engineering applications of MSCs, highlighting the development of vascularized tissue engineering constructs using microvascular free flaps as a novel tissue engineering strategy.

Entities:  

Mesh:

Year:  2006        PMID: 17237555     DOI: 10.1007/s12015-006-0023-x

Source DB:  PubMed          Journal:  Stem Cell Rev        ISSN: 1550-8943            Impact factor:   5.739


  54 in total

1.  Principles of tissue engineered regeneration of skeletal tissues.

Authors:  A I Caplan; V M Goldberg
Journal:  Clin Orthop Relat Res       Date:  1999-10       Impact factor: 4.176

2.  Tissue-engineered bone regeneration.

Authors:  H Petite; V Viateau; W Bensaïd; A Meunier; C de Pollak; M Bourguignon; K Oudina; L Sedel; G Guillemin
Journal:  Nat Biotechnol       Date:  2000-09       Impact factor: 54.908

3.  Osteogenetic activity of transplanted transitional epithelium.

Authors:  A J FRIEDENSTEIN
Journal:  Acta Anat (Basel)       Date:  1961

Review 4.  Biology of cord blood cells and future prospects for enhanced clinical benefit.

Authors:  H E Broxmeyer
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

5.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

6.  Cartilage engineering from ovine umbilical cord blood mesenchymal progenitor cells.

Authors:  Julie R Fuchs; Didier Hannouche; Shinichi Terada; Sarvenaz Zand; Joseph P Vacanti; Dario O Fauza
Journal:  Stem Cells       Date:  2005-08       Impact factor: 6.277

7.  The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells.

Authors:  A J Friedenstein; R K Chailakhjan; K S Lalykina
Journal:  Cell Tissue Kinet       Date:  1970-10

Review 8.  Tissue engineering.

Authors:  R Langer; J P Vacanti
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

9.  Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors.

Authors:  Rahul Sarugaser; David Lickorish; Dolores Baksh; M Morris Hosseini; John E Davies
Journal:  Stem Cells       Date:  2005-02       Impact factor: 6.277

10.  In vitro cartilage regeneration from proliferated adult elastic chondrocytes.

Authors:  Shinichi Terada; Julie R Fuchs; Hiroshi Yoshimoto; Dario O Fauza; Joseph P Vacanti
Journal:  Ann Plast Surg       Date:  2005-08       Impact factor: 1.539

View more
  12 in total

1.  Chondrogenesis from umbilical cord blood cells stimulated with BMP-2 and BMP-6.

Authors:  Cristiane Sampaio de Mara; A S S Duarte; A R Sartori-Cintra; A C M Luzo; S T O Saad; I B Coimbra
Journal:  Rheumatol Int       Date:  2012-01-12       Impact factor: 2.631

Review 2.  Immune regulatory cells in umbilical cord blood and their potential roles in transplantation tolerance.

Authors:  Young-June Kim; Hal E Broxmeyer
Journal:  Crit Rev Oncol Hematol       Date:  2010-08-19       Impact factor: 6.312

3.  Orthopedic cellular therapy: An overview with focus on clinical trials.

Authors:  Moon Jong Noh; Kwan Hee Lee
Journal:  World J Orthop       Date:  2015-11-18

4.  Mesenchymal stem cells: from biology to clinical use.

Authors:  Mauro Krampera; Massimo Franchini; Giovanni Pizzolo; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2007-07       Impact factor: 3.443

5.  Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.

Authors:  Karen Bieback; Irena Brinkmann
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

Review 6.  Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells.

Authors:  Wesley M Jackson; Leon J Nesti; Rocky S Tuan
Journal:  Expert Opin Biol Ther       Date:  2010-04       Impact factor: 4.388

Review 7.  Cell-based therapy for prevention and reversal of myocardial remodeling.

Authors:  Vasileios Karantalis; Wayne Balkan; Ivonne H Schulman; Konstantinos E Hatzistergos; Joshua M Hare
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-05-25       Impact factor: 4.733

Review 8.  Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation.

Authors:  Yong-Can Huang; Zhi-Ming Yang; Xiao-He Chen; Mei-Yun Tan; Jia Wang; Xiu-Qun Li; Hui-Qi Xie; Li Deng
Journal:  Stem Cell Rev Rep       Date:  2009-05-23       Impact factor: 5.739

Review 9.  Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells.

Authors:  Jakub Tolar; Keli L Hippen; Bruce R Blazar
Journal:  Br J Haematol       Date:  2009-10       Impact factor: 6.998

Review 10.  Mesenchymal stem cell therapy for attenuation of scar formation during wound healing.

Authors:  Wesley M Jackson; Leon J Nesti; Rocky S Tuan
Journal:  Stem Cell Res Ther       Date:  2012-05-31       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.